4
Changes in Ownership
Zentalis Pharmaceuticals, Inc. Filed Acc 0000899243-20-010601
Chief Operating Officer acquired 99,246 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bunker Kevin D. · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-04-07 | Grant or award : show line 1 in the form | +99,246 | 544,650 | D |
Loading xslF345X03/doc4.xml…